Create an account to read this article
You need to create an account to read this article.
Create Account Sign in
Diabetes and Endocrinology
Cardiology and CTVS
Medicine
Early Initiation Of SGLT2 Inhibitors Reduces MACE In Type 2 Diabetes Patients At ASCVD Risk
0 Comments
Post a comment
No comments yet. Be the first to comment!